Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...

Shenni Holdings plans a $15M IPO to expand in third-party medical devices. Learn about their growth, risks, and valuation ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Australia faces a potential tariff of between 2 per cent and 8 per cent on the $30 billion of exports sold to the United ...

While China has become a key country for global clinical trials, navigating regulatory complexities and ensuring data ...

The development is set to make India less reliant on China for imports of raw material used by the pharmaceutical industry.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...

Lizzi C. Lee speaks with Gary Rieschel about what's behind China's biotech boom, potential risks, and long-term global ...

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...